How Current Research Shapes the Future of MS Care: A Recap of Our Successful Symposium

By Nicolas Ruffin, Associate Professor at the Department of Clinical Neuroscience, Karolinska Institutet. 

The event kicked off with an insightful presentation by Professor Fredrik Piehl, who provided an overview of current MS therapies and the emerging challenges we face. Dr. Olivia Thomas followed with a discussion on the link between Epstein-Barr virus (EBV) and MS, exploring the potential role of EBV in triggering the immune response that leads to MS. Dr. Lara Kular delved into the complexities of progressive MS, offering valuable insights gleaned from the study of epigenetics, the field that explores the factors, including environmental/lifestyle exposures, can influence gene expression.

The second session shifted focus to patient care and support. Anna Cunningham from MS-fonden discussed the importance of increasing knowledge and competence of MS among health professionals, highlighting the need for continued education and awareness initiatives. Representatives from Neuroförbundet, Helene Landersten and Eva Helmersson, provided insightful perspectives on supporting people living with neurological diagnoses. Additionally, a representative from Neuroförbundet shared the experiences and challenges faced by people living with MS, offering a crucial first-hand perspective.

The scientific program continued with presentations exploring promising new avenues for MS treatment. Dr. Heela Sarlus shared findings of her research on placental stem cell therapy and its potential to reduce disease progression in MS-like conditions. Dr. Rasmus Berglund presented the molecular mechanisms of brain aging and their potential connection to MS. Prof. Gonçalo Castelo-Branco wrapped up the program with a discussion on disease-associated oligodendroglia in MS, shedding light on their role in the disease process through the lens of advanced omics technologies.

The final hour of the symposium was dedicated to a lively poster session and networking opportunities. This provided a platform for researchers to showcase their work, enhance collaboration, and engage in stimulating discussions with attendees.

Overall, the symposium proved to be a resounding success. By bringing together leading researchers, clinicians, patient advocates, and people living with MS, the event fostered a comprehensive and collaborative discussion on the future of MS care. The insights gleaned from the presentations and discussions will undoubtedly shape the direction of future research and pave the way for improved patient outcomes.

The symposium was organized by Associate Professor Nicolas Ruffin, with the help of Dr Chiara Starvaggi Cucuzza, Dr Urszula Rykaczewska and Dr Lara Kular, from the Center of Molecular Medicine.

https://news.ki.se/calendar/how-current-research-shapes-the-future-of-ms-care